Skip to main content
. 2022 Sep 8;13:938961. doi: 10.3389/fendo.2022.938961

Table 4.

The prevalence of malignancy in each C-TIRADS classification.

Classification No. of malignant nodules Total no. of nodules Prevalence of malignancy (%) Suggested malignancy risk (%)
C-TIRADS 2 0 370 0% 0%
C-TIRADS 3 31 2,271 1.37% <2%
C-TIRADS 4A 301 2,834 10.62% 2–10%
C-TIRADS 4B 854 2,134 40.02% 10–50%
C-TIRADS 4C 2,763 3,544 77.96% 50–90%
C-TIRADS 5 334 353 94.62% >90%

C-TIRADS, Chinese thyroid imaging reports and data systems.